In 2017, UK HealthCare neurologist Ima Ebong, M.D., had just begun her clinical neurophysiology fellowship training and had just become a mother for the first time. It had been her happiest and most successful year to date, but everything changed when she was diagnosed with stage 3 colon cancer at just 35 years old. Now cancer-free, Ebong hopes her story will help spread awareness about colorectal cancer, especially to people who are disproportionately impacted by the disease.
A new drug regimen for certain types of pancreatic cancer recently got approval from the FDA the first new medication in nearly a decade. Physicians weigh in on what it means.
PanCAN’s Scientific & Medical Advisory Board (SMAB) welcomes new leadership and members, representing the foremost expertise in the field of pancreatic cancer from institutions across the US.
Nonprofit’s Scientific and Medical Advisory Board Represented by Foremost Leaders in Pancreatic Cancer Field LOS ANGELES, Calif. – (July 18, [.] READ MORE
/PRNewswire/ The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, proudly announces the addition of.